American Century Companies Inc Acadia Pharmaceuticals Inc Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, American Century Companies Inc holds 91,027 shares of ACAD stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,027

Previous 73,148 24.44%

Holding current value

$1.55 Million

Previous $1.19 Million 17.85%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $270,688 - $342,204	17,879 Added 24.44%	91,027 $1.4 Million
Q2 2024 Aug 07, 2024	BUY	$14.62 - $18.42 $464,360 - $585,056	31,762 Added 76.75%	73,148 $1.19 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $736,256 - $1.28 Million	41,386 New	41,386 $765,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $2.44 Million - $3.92 Million	117,092 Added 731.64%	133,096 $2.77 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $284,871 - $410,502	16,004 New	16,004 $383,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $151,033 - $315,996	-11,609 Reduced 26.25%	32,619 $460,000
Q1 2022 May 11, 2022	SELL	$20.94 - $27.5 $18,427 - $24,200	-880 Reduced 1.95%	44,228 $1.07 Million
Q4 2021 Feb 07, 2022	BUY	$16.79 - $27.09 $757,363 - $1.22 Million	45,108 New	45,108 $1.05 Million
Q2 2021 Aug 05, 2021	SELL	$19.4 - $27.42 $4.82 Million - $6.81 Million	-248,505 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $24 Million - $52.8 Million	-960,572 Reduced 79.45%	248,505 $6.41 Million
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $132,600 - $183,488	3,231 Added 0.27%	1,209,077 $64.6 Million
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $3.92 Million - $6.13 Million	107,501 Added 9.79%	1,205,846 $49.7 Million
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $6.71 Million - $9.01 Million	170,910 Added 18.43%	1,098,345 $53.2 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $22.2 Million - $32.9 Million	702,188 Added 311.74%	927,435 $39.2 Million
Q4 2019 Feb 12, 2020	BUY	$36.21 - $51.4 $2.5 Million - $3.55 Million	69,100 Added 44.25%	225,247 $9.64 Million
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $3.47 Million - $6.87 Million	156,147 New	156,147 $5.62 Million
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $2.12 Million - $3.39 Million	-147,949 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$13.03 - $21.81 $10,410 - $17,426	-799 Reduced 0.54%	147,949 $3.07 Million
Q2 2018 Aug 08, 2018	BUY	$15.07 - $22.34 $2.24 Million - $3.32 Million	148,748 New	148,748 $2.27 Million
Q4 2017 Feb 02, 2018	SELL	$26.84 - $39.14 $481,778 - $702,563	-17,950 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$29.49 - $38.37 $529,345 - $688,741	17,950	17,950 $676,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Acadia Pharmaceuticals Inc Transaction History